DDOG vs SGMO · P/E 292, rev $3.43B vs rev $57.8M
Datadog Inc (DDOG) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported DDOG revenue for 2025-12-31 was $3.43B. Net income was $107.7M. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
DDOG currently screens at market cap $47.44B and trailing P/E 292.3. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the DDOG and SGMO stock pages for the full models.
Not investment advice.